Description
This formulation combines compounds commonly discussed in research involving growth hormone-related signaling pathways. Ipamorelin acts as a ghrelin-receptor agonist, while CJC-related peptides have been investigated for effects on growth hormone-releasing pathways. This combination should not be presented as an approved medical treatment without appropriate regulatory evidence.

Reviews
There are no reviews yet.